Determination of Residual Anticoagulatory Effects of Fondaparinux

Johann Wolfgang Goethe University Hospital110 enrolled

Overview

The purpose of this study is to determine residual anticoagulatory effects of a prophylactic or therapeutic fondaparinux treatment i.e. prior to surgery/intervention, after pause of therapy etc.

Study Type

OBSERVATIONAL

Enrollment

110

Conditions

Anticoagulant Prophylaxis/Therapy

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Fondaparinux therapy for at least 3 days Exclusion Criteria: * Age \< 18 years * Hemodialysis

Locations (1)

J.W. Goethe University Hospital Frankfurt/M.

Frankfurt am Main, Hesse, Germany

RECRUITING

Outcomes

Primary Outcomes

antiXa-levels (peak- and through-levels)

Time frame: between day 3 and day 14 after start of therapy

Secondary Outcomes

thromboembolic or bleeding episodes, HIT

Time frame: day 14 after start of therapy

Central Contacts

Marc Schindewolf, MD

CONTACT

+49 (0)69 6301 marcschindewolf@yahoo.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.